Per the deal terms, Sanofi took a minority stake in NVAX (a $70 million equity investment), will gain rights to co-market Novavax’s COVID-19 vaccine globally, and will have the sole license to ...

Novavax's exclusive dependence on Serum Institute of India Pvt. Ltd. for co-formulation and filling and the impact of any delays or disruptions in their operations on the delivery of customer ...

Novavax received the green light from the Food ... In May, it struck a $1.2 billion licensing agreement with French drugmaker Sanofi to co-commercialize the combination vaccine.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY).

The latest flu vaccines are now available, and just like the COVID-19 shots, it's recommended to get the flu shot in ...

Novavax's exclusive dependence on Serum Institute of India Pvt. Ltd. for co-formulation and filling and the impact of any delays or disruptions in their operations on the delivery of customer ...

Novavax NVAX announced that the FDA granted emergency use authorization (EUA) to an updated version of its protein-based ...

Medicare, Medicaid, and many private insurance plans cover the cost of adult Covid vaccinations. Children can get the shots ...

3 variant. New vaccines from Pfizer, Moderna, and Novavax are currently under review for approval by the Ministry of Food and Drug Safety, the official added. The disease agency plans to purchase ...

COVID-19 rates are rising again in Iowa, according to new state and federal data, as the FDA approved emergency use of new vaccines to combat rising spread of variants.